Living Cell Technologies Limited LCT.AX Stock
Living Cell Technologies Limited Price Chart
Living Cell Technologies Limited LCT.AX Financial and Trading Overview
| Living Cell Technologies Limited stock price | 0.01 AUD |
| Previous Close | 0.01 AUD |
| Open | 0.01 AUD |
| Bid | 0.01 AUD x 0 |
| Ask | 0.01 AUD x 0 |
| Day's Range | 0.01 - 0.01 AUD |
| 52 Week Range | 0.007 - 0.02 AUD |
| Volume | 536.38K AUD |
| Avg. Volume | 644.75K AUD |
| Market Cap | 18.72M AUD |
| Beta (5Y Monthly) | 0.2659 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 AUD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
LCT.AX Valuation Measures
| Enterprise Value | 12.34M AUD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 5498.2905 |
| Price/Book (mrq) | 6 |
| Enterprise Value/Revenue | 3623.703 |
| Enterprise Value/EBITDA | -6.909 |
Trading Information
Living Cell Technologies Limited Stock Price History
| Beta (5Y Monthly) | 0.2659 |
| 52-Week Change | 71.42% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.02 AUD |
| 52 Week Low | 0.007 AUD |
| 50-Day Moving Average | 0.00976 AUD |
| 200-Day Moving Average | 0.01 AUD |
LCT.AX Share Statistics
| Avg. Volume (3 month) | 644.75K AUD |
| Avg. Daily Volume (10-Days) | 740.79K AUD |
| Shares Outstanding | 1.56B |
| Float | 932.69M |
| Short Ratio | N/A |
| % Held by Insiders | 29.65% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | June 30, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | June 30, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -52412.18% |
| Gross Margin | 100.00% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -29.46% |
| Return on Equity (ttm) | -74.28% |
Income Statement
| Revenue (ttm) | 3.41K AUD |
| Revenue Per Share (ttm) | 0 AUD |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | 3.41K AUD |
| EBITDA | -1785909 AUD |
| Net Income Avi to Common (ttm) | -2529817 AUD |
| Diluted EPS (ttm) | 0 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 3.09M AUD |
| Total Cash Per Share (mrq) | 0.002 AUD |
| Total Debt (mrq) | 0 AUD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 8.127 |
| Book Value Per Share (mrq) | 0.002 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -2597148 AUD |
| Levered Free Cash Flow (ttm) | -1138760 AUD |
Profile of Living Cell Technologies Limited
| Country | Australia |
| State | VIC |
| City | Melbourne |
| Address | Rialto South Tower |
| ZIP | 3000 |
| Phone | 61 3 8689 9997 |
| Website | https://www.lctglobal.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Living Cell Technologies Limited, a biotechnology company, discovers, develops, and commercializes regenerative treatments that use naturally occurring cells to restore functions in Australia and New Zealand. It is developing NTCELL, an alginate-coated capsule, which is in phase IIb clinical trial for the treatment of Parkinson's disease. The company was founded in 1987 and is based in Melbourne, Australia.
Q&A For Living Cell Technologies Limited Stock
What is a current LCT.AX stock price?
Living Cell Technologies Limited LCT.AX stock price today per share is 0.01 AUD.
How to purchase Living Cell Technologies Limited stock?
You can buy LCT.AX shares on the ASX exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Living Cell Technologies Limited?
The stock symbol or ticker of Living Cell Technologies Limited is LCT.AX.
Which industry does the Living Cell Technologies Limited company belong to?
The Living Cell Technologies Limited industry is Biotechnology.
How many shares does Living Cell Technologies Limited have in circulation?
The max supply of Living Cell Technologies Limited shares is 1.64B.
What is Living Cell Technologies Limited Price to Earnings Ratio (PE Ratio)?
Living Cell Technologies Limited PE Ratio is 0.00000000 now.
What was Living Cell Technologies Limited earnings per share over the trailing 12 months (TTM)?
Living Cell Technologies Limited EPS is 0 AUD over the trailing 12 months.
Which sector does the Living Cell Technologies Limited company belong to?
The Living Cell Technologies Limited sector is Healthcare.